These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 9748318

  • 1. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A, Plückthun A.
    Biochemistry; 1998 Sep 22; 37(38):13120-7. PubMed ID: 9748318
    [Abstract] [Full Text] [Related]

  • 2. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH, Sandmaier BM, Stayton PS.
    Biophys J; 1998 Sep 22; 75(3):1473-82. PubMed ID: 9726949
    [Abstract] [Full Text] [Related]

  • 3. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering.
    Wörn A, Plückthun A.
    Biochemistry; 1999 Jul 06; 38(27):8739-50. PubMed ID: 10393549
    [Abstract] [Full Text] [Related]

  • 4. Antibody scFv fragments without disulfide bonds made by molecular evolution.
    Proba K, Wörn A, Honegger A, Plückthun A.
    J Mol Biol; 1998 Jan 16; 275(2):245-53. PubMed ID: 9466907
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
    Proba K, Honegger A, Plückthun A.
    J Mol Biol; 1997 Jan 17; 265(2):161-72. PubMed ID: 9020980
    [Abstract] [Full Text] [Related]

  • 7. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
    Röthlisberger D, Honegger A, Plückthun A.
    J Mol Biol; 2005 Apr 08; 347(4):773-89. PubMed ID: 15769469
    [Abstract] [Full Text] [Related]

  • 8. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L.
    J Mol Biol; 1996 Jun 28; 259(5):957-69. PubMed ID: 8683598
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
    Arndt KM, Müller KM, Plückthun A.
    Biochemistry; 1998 Sep 15; 37(37):12918-26. PubMed ID: 9737871
    [Abstract] [Full Text] [Related]

  • 10. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly.
    Wörn A, Plückthun A.
    FEBS Lett; 1998 May 15; 427(3):357-61. PubMed ID: 9637257
    [Abstract] [Full Text] [Related]

  • 11. [Recombinant design and expression of human three-domain antibody against BoNTa].
    Wang H, Yin J, Shi J, Meng LL, Li PZ.
    Wei Sheng Wu Xue Bao; 2005 Apr 15; 45(2):223-5. PubMed ID: 15989265
    [Abstract] [Full Text] [Related]

  • 12. Crystallization of single-chain Fv proteins.
    Essig NZ, Wood JF, Howard AJ, Raag R, Whitlow M.
    J Mol Biol; 1993 Dec 05; 234(3):897-901. PubMed ID: 8254684
    [Abstract] [Full Text] [Related]

  • 13. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.
    Langedijk AC, Honegger A, Maat J, Planta RJ, van Schaik RC, Plückthun A.
    J Mol Biol; 1998 Dec 05; 283(1):95-110. PubMed ID: 9761676
    [Abstract] [Full Text] [Related]

  • 14. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.
    Kim YJ, Neelamegam R, Heo MA, Edwardraja S, Paik HJ, Lee SG.
    J Microbiol Biotechnol; 2008 Jun 05; 18(6):1186-90. PubMed ID: 18600066
    [Abstract] [Full Text] [Related]

  • 15. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
    Jäger M, Plückthun A.
    J Mol Biol; 1999 Feb 05; 285(5):2005-19. PubMed ID: 9925781
    [Abstract] [Full Text] [Related]

  • 16. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
    Jäger M, Gehrig P, Plückthun A.
    J Mol Biol; 2001 Feb 02; 305(5):1111-29. PubMed ID: 11162118
    [Abstract] [Full Text] [Related]

  • 17. [New type recombinant antibody fragment scFv multimer and cancer targeting].
    Guo J, Cai M.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun 02; 20(2):361-5. PubMed ID: 12856620
    [Abstract] [Full Text] [Related]

  • 18. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
    Khalifa MB, Weidenhaupt M, Choulier L, Chatellier J, Rauffer-Bruyère N, Altschuh D, Vernet T.
    J Mol Recognit; 2000 Jun 02; 13(3):127-39. PubMed ID: 10867708
    [Abstract] [Full Text] [Related]

  • 19. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J, Van Regenmortel MH, Vernet T, Altschuh D.
    J Mol Biol; 1996 Nov 22; 264(1):1-6. PubMed ID: 8950262
    [Abstract] [Full Text] [Related]

  • 20. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.
    Arndt KM, Müller KM, Plückthun A.
    J Mol Biol; 2001 Sep 07; 312(1):221-8. PubMed ID: 11545598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.